SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLS Holdings Regulatory News (CLI)

Share Price Information for CLS Holdings (CLI)

Share Price is delayed by 15 minutes
Get Live Data
48.65    0.95 (1.99%)
Bid:
47.80
Ask:
49.65
Spread: 1.85 (3.87%)
Market Cap: £193.68m
CLI Live PriceLast checked at - London Stock Exchange

Intraday CLS Holdings Share Chart

Acquisition

17 Feb 2022 07:00

RNS Number : 9338B
CLS Holdings PLC
17 February 2022
 

 

Release date: 17 February 2022

Embargoed until: 07:00 am

 

 

CLS Holdings plc ("CLS" or the "Group")

announces the €25 million acquisition of an office building in Dusseldorf

 

CLS announces that is has unconditionally exchanged contracts to acquire a 9,168 sqm / 98,684 sq. ft office building in Dusseldorf for €25 million (€2,724 per sqm) excluding costs from alstria office REIT-AG.

 

Kanzlerstraße 8 is situated in a well-connected and growing submarket in Dusseldorf. The overground station, Dusseldorf Rath, and the underground station, Rather Waldstadion, are both within 400m of the asset. The airport can be reached within 10 minutes by car and the central station in 16 minutes by overground. Dusseldorf is one of the main political, economic, and cultural centre of the Rhine-Ruhr region with a population of c. 11 million and one of the "Top 7" office markets.

 

The property is currently occupied by three tenants including the anchor tenant Amevida (c. 70% by space), Kinderparadies, and ConSol with a WAULT of c. 8 years. CLS plans to let remaining vacant space, enhance the carpark and ESG credentials, and manage the future lease breaks. The property currently has a net initial yield of 5.1% and a reversionary yield of 5.7%.

 

The acquisition is expected to complete in April 2022.

 

Fredrik Widlund, Chief Executive Officer of CLS, commented:

 

"This asset is a well-located office building and benefits from an existing strong tenant base with the opportunity to secure market rents and valuation uplifts in the years ahead. This acquisition also reflects our confidence in the underlying strength of the German office market, particularly in key regional cities. We look forward to working with the tenants to improve the building further and enhancing its sustainability."

 

-ends-

For further information, please contact:

 

CLS Holdings plc

(LEI: 213800A357TKB2TD9U78)

www.clsholdings.com

Fredrik Widlund, Chief Executive Officer

Andrew Kirkman, Chief Financial Officer

+44 (0)20 7582 7766

 

Liberum Capital

Richard Crawley

Jamie Richards

+44 (0)20 3100 2222

 

Panmure Gordon

Hugh Rich

+44 (0)20 7886 2733

 

Berenberg

Matthew Armitt

Richard Bootle

+44 (0)20 3207 7800

 

Edelman Smithfield (Financial PR)Alex Simmons

Rob Yates

+44 (0)20 3047 2000

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQFZGMZZVZGZZZ
Date   Source Headline
13th Mar 20187:00 amRNSAcquisition
12th Mar 20185:43 pmRNSDirector/PDMR Shareholding
8th Mar 20185:42 pmRNSDirector/PDMR Shareholding
8th Mar 20185:35 pmRNSDirector/PDMR Shareholding
7th Mar 20187:00 amRNSFinal Results
9th Feb 20185:19 pmRNSDirector/PDMR Shareholding
7th Feb 201812:02 pmRNSPrice Monitoring Extension
19th Jan 20187:00 amRNSChange of Joint Corporate Broker
9th Jan 20185:35 pmRNSDirector/PDMR Shareholding
3rd Jan 20187:00 amRNSDisposals
21st Dec 201712:07 pmRNSSecond Price Monitoring Extn
21st Dec 201712:02 pmRNSPrice Monitoring Extension
7th Dec 20175:10 pmRNSDirector/PDMR Shareholding
7th Dec 201712:15 pmRNSDirectorate Change
9th Nov 20177:00 amRNSAcquisition
8th Nov 20174:24 pmRNSDirector/PDMR Shareholding
1st Nov 20177:00 amRNSDisposal
25th Oct 20171:43 pmRNSEarly redemption of outstanding amortising bonds
9th Oct 20175:25 pmRNSDirector/PDMR Shareholding
4th Oct 20177:00 amRNSRenewal of Government Leases
22nd Sep 20179:47 amRNSDirector/PDMR Shareholding
21st Sep 20177:00 amRNSDisposal
11th Sep 201711:52 amRNSDirector/PDMR Shareholding
22nd Aug 20177:00 amRNSCompletion of German portfolio acquisition
16th Aug 201711:28 amRNSDividend Timetable
16th Aug 20177:00 amRNSHalf-year Report
9th Aug 201712:31 pmRNSDirector/PDMR Shareholding
22nd Jun 20174:35 pmRNSPrice Monitoring Extension
14th Jun 20177:00 amRNSAcquisition
30th May 20177:00 amRNSAcquisition
17th May 20174:35 pmRNSPrice Monitoring Extension
16th May 20173:40 pmRNSDirectorate Change
8th May 20179:24 amRNSCompletion of Share Subdivision & TVR
4th May 201711:21 amRNSCompletion of Sale of Vauxhall Square
28th Apr 20172:52 pmRNSDirector/PDMR Shareholding
26th Apr 20174:02 pmRNSShare Subdivision Timetable
26th Apr 20173:26 pmRNSDirector/PDMR Shareholding
26th Apr 20173:21 pmRNSResult of AGM
5th Apr 201712:14 pmRNSSale of Vauxhall Square
24th Mar 20174:39 pmRNSPublication of Annual Report and Notice of AGM
23rd Mar 20177:00 amRNSDisposal
21st Mar 20177:00 amRNSAcquisition
15th Mar 20174:07 pmRNSDividend Timetable
8th Mar 20177:00 amRNSFinal Results
7th Mar 20173:57 pmRNSDirectorate Changes
8th Feb 20177:00 amRNSIntroduction of Dividend
18th Jan 20174:22 pmRNSTrading Statement
11th Jan 20177:00 amRNSAcquisitions
16th Dec 20164:40 pmRNSSecond Price Monitoring Extn
16th Dec 20164:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.